isospaglumic acid has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altmann, DR; Chard, DT; Davies, G; Griffin, CM; McLean, MA; Miller, DH; Rashid, W; Sastre-Garriga, J; Thompson, AJ; Tiberio, M | 1 |
| Cipolotti, L; Dalton, C; Fernando, K; Miller, DH; Ron, MA; Summers, M; Swanton, J | 1 |
2 other study(ies) available for isospaglumic acid and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
Topics: Adult; Aspartic Acid; Choline; Creatine; Dipeptides; Female; Follow-Up Studies; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Statistics, Nonparametric; Time Factors | 2006 |
Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease.
Topics: Adolescent; Adult; Aspartic Acid; Atrophy; Brain; Cerebral Ventricles; Cognition Disorders; Cohort Studies; Dipeptides; Disability Evaluation; Female; Follow-Up Studies; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neurologic Examination; Neuropsychological Tests; Predictive Value of Tests; Prospective Studies | 2008 |